9530 Stock Overview
Arabian International Healthcare Holding Company supplies healthcare equipment and solutions in the Kingdom of Saudi Arabia.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Arabian International Healthcare Holding Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ر.س42.00 |
52 Week High | ر.س45.20 |
52 Week Low | ر.س37.00 |
Beta | 0.70 |
1 Month Change | -0.71% |
3 Month Change | 9.66% |
1 Year Change | -1.64% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -46.77% |
Recent News & Updates
Shareholder Returns
9530 | SA Healthcare | SA Market | |
---|---|---|---|
7D | -2.3% | 2.9% | 0.2% |
1Y | -1.6% | 18.9% | -4.3% |
Return vs Industry: 9530 underperformed the SA Healthcare industry which returned 17.1% over the past year.
Return vs Market: 9530 exceeded the SA Market which returned -4.9% over the past year.
Price Volatility
9530 volatility | |
---|---|
9530 Average Weekly Movement | 3.4% |
Healthcare Industry Average Movement | 4.4% |
Market Average Movement | 4.9% |
10% most volatile stocks in SA Market | 8.1% |
10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 9530 has not had significant price volatility in the past 3 months.
Volatility Over Time: 9530's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | n/a | Alaa Ahmed Abdul Amin | www.tibbiyah.com |
Arabian International Healthcare Holding Company supplies healthcare equipment and solutions in the Kingdom of Saudi Arabia. The company operates through Medical Devices and Medical Supplies segments. It offers medical devices, consumables, personal aids, implants, and other products.
Arabian International Healthcare Holding Company Fundamentals Summary
9530 fundamental statistics | |
---|---|
Market cap | ر.س838.11m |
Earnings (TTM) | ر.س23.64m |
Revenue (TTM) | ر.س743.40m |
35.2x
P/E Ratio1.1x
P/S RatioIs 9530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9530 income statement (TTM) | |
---|---|
Revenue | ر.س743.40m |
Cost of Revenue | ر.س567.07m |
Gross Profit | ر.س176.32m |
Other Expenses | ر.س152.68m |
Earnings | ر.س23.64m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.19 |
Gross Margin | 23.72% |
Net Profit Margin | 3.18% |
Debt/Equity Ratio | 165.9% |
How did 9530 perform over the long term?
See historical performance and comparison